Thursday, October 11, 2012

Medical Marijuana: No More Pipe Dream

 

Diane Riportella, an ALS patient and medical marijuana user, who died weeks ago - before seeing implementation of the law she fought for.
 
 
 
 
 
 
 
 "Medical Marijuana: No More Pipe Dream"
 
 
 The first episode of our new season is now available online:
 
NJ TV LOGO
 
There are still some who say that the law is flawed, too restrictive, and others who insist that allowing any legal marijuana is flawed thinking.
 
But like it or hate it, medical marijuana is almost here. New Jersey's first authorized distribution center is expected to open within weeks, in a Montclair storefront that once housed a head shop.
 
On this edition of "Due Process," we look at the rationale - and the strict state rules - for legalizing the use of marijuana to ease the suffering of the critically ill.
 
And we look back at the life of Diane Riportella, an ALS patient for whom other drugs proved useless. It was her tearful plea to state legislators that helped win passage of the "compassionate use" bill. She died just weeks ago, before she could see the law she fought for put in practice.
 
In the studio, Sandra King and Raymond Brown get all sides of the still-controversial law from Senate Sponsor Nicholas Scutari, former Ocean County 1st Asst. Prosecutor Terrence Farley and Critical Care Doctor Jeffrey Miskoff.
 
Due Process - winner of 21 New York and Mid-Atlantic Emmys - airs on NJTV, successor to New Jersey Network, on the stations and cable positions once occupied by NJN.
 
Due Process is a production of Rutgers School of Law - Newark and the Edward J. Bloustein School of Planning and Public Policy with studio facilities provided by the Rutgers iTV Studio, Division of Continuing Studies.
 
Major funding for Due Process is provided by The Fund for New Jersey and Rutgers, The State University.
  
Watch our programs on-line on our YouTube Channel:
View our videos on YouTube

We'd be grateful if you'd become a "fan" of Due Process
Like us on Facebook
or follow us on Twitter
Follow us on Twitter






No comments:

Post a Comment